General Information of the Protein
Protein ID
PT01446
Protein Name
Interleukin-8
Secondarily
Protein Name
C-X-C motif chemokine 8
Chemokine (C-X-C motif) ligand 8
Emoctakin
Granulocyte chemotactic protein 1
Monocyte-derived neutrophil chemotactic factor
Monocyte-derived neutrophil-activating peptide
Neutrophil-activating protein 1
Protein 3-10C
T-cell chemotactic factor
GCP/IL-8 protein IV
IL8/NAP1 form I
(Ala-IL-8)77
GCP/IL-8 protein II
IL-8(1-77)
IL8/NAP1 form II
MDNCF-b
(Ser-IL-8)72
GCP/IL-8 protein I
IL8/NAP1 form III
Lymphocyte-derived neutrophil-activating factor
MDNCF-c
Neutrophil-activating factor
GCP/IL-8 protein V
IL8/NAP1 form IV
GCP/IL-8 protein VI
IL8/NAP1 form V
GCP/IL-8 protein III
IL8/NAP1 form VI
Gene Name
CXCL8
Secondarily
Gene Name
IL8
Sequence
MTSKLAVALLAAFLISAALCEGAVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Secreted protein
Function
Chemotactic factor that mediates inflammatory response by attracting neutrophils, basophils, and T-cells to clear pathogens and protect the host from infection (PubMed:7636208, PubMed:18692776). Also plays an important role in neutrophil activation (PubMed:9623510, PubMed:2145175). Released in response to an inflammatory stimulus, exerts its effect by binding to the G-protein-coupled receptors CXCR1 and CXCR2, primarily found in neutrophils, monocytes and endothelial cells (PubMed:1840701, PubMed:1891716). G-protein heterotrimer (alpha, beta, gamma subunits) constitutively binds to CXCR1/CXCR2 receptor and activation by IL8 leads to beta and gamma subunits release from Galpha (GNAI2 in neutrophils) and activation of several downstream signaling pathways including PI3K and MAPK pathways (PubMed:8662698, PubMed:11971003).
    Show/Hide
Uniprot ID
Primary ID:
P10145

Secondarily ID:
B2R4L8
Q6FGF6
Q6LAE6
Q96RG6
Q9C077
Q9UCE1
Q9UCR8
Q9UCR9
Q9UCS0
    Show/Hide
Ensembl ID
ENSG00000169429
HGNC ID
HGNC:6025
Subcellular Location
Secreted
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000892 , MCF-7/NOD1
Compound ID Compound Name Compound Formula
CP0068491
1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine
   Show/Hide
C13H10ClN3O2S
 2
1
IC50 = 1460 nM
   TI
   LI
   LO
   TS
2
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CP0194694
3-methyl-8-nitro-7-(phenylmethyl)purine-2,6-dione
   Show/Hide
C13H11N5O4
 2
1
IC50 = 2156 nM
   TI
   LI
   LO
   TS
2
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0372586
(1-besylbenzimidazol-2-yl)amine
   Show/Hide
C13H11N3O2S
 2
1
IC50 = 2410 nM
   TI
   LI
   LO
   TS
2
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CP0385714
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine
   Show/Hide
C14H13N3O3S
 2
1
IC50 = 3130 nM
   TI
   LI
   LO
   TS
2
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CP0379980
3-methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dione
   Show/Hide
C16H18N4O2S
 2
1
IC50 = 3310 nM
   TI
   LI
   LO
   TS
2
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0047507
7-[(E)-but-2-enyl]-3-methyl-8-(3-phenylpropylsulfanyl)purine-2,6-dione
   Show/Hide
C19H22N4O2S
 2
1
IC50 = 3430 nM
   TI
   LI
   LO
   TS
2
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0380859
3-methyl-7-pentyl-8-(2-phenylethylsulfanyl)purine-2,6-dione
   Show/Hide
C19H24N4O2S
 2
1
IC50 = 4100 nM
   TI
   LI
   LO
   TS
2
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0437413
1-[2-(4-chloranylphenoxy)ethyl]benzimidazol-2-amine
   Show/Hide
C15H14ClN3O
 2
1
IC50 = 8600 nM
   TI
   LI
   LO
   TS
2
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0379409
1-[(4-chlorophenyl)methyl]-2-benzimidazolamine
   Show/Hide
C14H12ClN3
 2
1
IC50 = 12110 nM
   TI
   LI
   LO
   TS
2
IC50 = 19840 nM
   TI
   LI
   LO
   TS
CP0377810
(5E)-5-[[2-(trifluoromethyl)phenyl]hydrazinylidene]-8-quinolinone
   Show/Hide
C16H10F3N3O
 2
1
IC50 = 19790 nM
   TI
   LI
   LO
   TS
2
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0073137
7-butyl-8-[[4-(3-chlorophenyl)-1-piperazinyl]methyl]-1,3-dimethylpurine-2,6-dione
   Show/Hide
C22H29ClN6O2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0360366
7-[(E)-but-2-enyl]-3-methyl-8-(phenylmethylsulfanyl)purine-2,6-dione
   Show/Hide
C17H18N4O2S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0385708
2-(2-amino-1-benzimidazolyl)-1-(4-methoxyphenyl)ethanone
   Show/Hide
C16H15N3O2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0385715
(2-amino-1-benzimidazolyl)-(2,4-dichlorophenyl)methanone
   Show/Hide
C14H9Cl2N3O
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0417548
7-[(E)-but-2-enyl]-8-[(4-chlorobenzyl)thio]-3-methyl-xanthine
   Show/Hide
C17H17ClN4O2S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0426431
3-methyl-8-(3-phenylpropylsulfanyl)-7-prop-2-enyl-purine-2,6-dione
   Show/Hide
C18H20N4O2S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0464450
6-methyl-3-(4-methylphenyl)sulfonyl-1H-benzimidazole-2-thione
   Show/Hide
C15H14N2O2S2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0470629
7-(2-methoxyethyl)-3-methyl-8-(3-phenylpropylsulfanyl)purine-2,6-dione
   Show/Hide
C18H22N4O3S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0471913
3-methyl-8-(3-phenylpropylsulfanyl)-7-propan-2-yl-purine-2,6-dione
   Show/Hide
C18H22N4O2S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0474489
MLS-0281326.0001
   Show/Hide
C17H16ClN3O
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0474490
7-Butyl-3-methyl-8-(2-oxo-2-phenyl-ethylsulfanyl)-3,7-dihydro-purine-2,6-dione
   Show/Hide
C18H20N4O3S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0478231
MLS000107619
   Show/Hide
C19H14ClN3O2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0483358
2-(7-butyl-1,3-dimethyl-2,6-dioxopurin-8-yl)sulfanyl-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide
   Show/Hide
C17H23N7O3S2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0494623
2-(1,3-Dimethyl-2,6-dioxo-7-propyl-2,3,6,7-tetrahydro-1H-purin-8-ylsulfanyl)-N-(4,5,6,7-tetrahydro-benzothiazol-2-yl)-acetamide
   Show/Hide
C19H24N6O3S2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0499532
7-[(E)-3-chloranylbut-2-enyl]-1,3-dimethyl-8-(2-phenylethylamino)purine-2,6-dione
   Show/Hide
C19H22ClN5O2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0529913
3-Methyl-8-phenethylsulfanyl-7-propyl-3,7-dihydro-purine-2,6-dione
   Show/Hide
C17H20N4O2S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0142376
(1-tosylbenzimidazol-2-yl)amine
   Show/Hide
C14H13N3O2S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0372480
2-(morpholin-4-ylcarbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid
   Show/Hide
C14H18N2O4S
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0134147
1-(4-methylphenyl)sulfonylbenzimidazole
   Show/Hide
C14H12N2O2S
 1
1
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CP0378226
(5,6-dimethyl-1-tosyl-benzimidazol-2-yl)amine
   Show/Hide
C16H17N3O2S
 1
1
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CP0474606
(1-nosylbenzimidazol-2-yl)amine
   Show/Hide
C13H10N4O4S
 1
1
IC50 > 5000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Interleukin-8 (IL8) )
Target Type Successful Target
Disease 1 Target-related Disease  1
1 Pain [ICD-11: MG30-MG3Z]
Approved Drug(s) 1 Approved Drug  1
1 Ibuprofen Approved
Pain
Target 2 ( HUMAN interleukin 8 (IL8) )
Target Type Unknown Type Target